Tech Company Financing Transactions
Sirnaomics Funding Round
Sirnaomics, based in Gaithersburg, secured $25 million in funding from Yuexiu New Industrial Investment, HuaKong Equity Investment and Qianhai Shenghui Investment.
Transaction Overview
Company Name
Announced On
6/8/2018
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Proceeds Purpose
The proceeds will be used to expand the clinical programs of the lead anti-fibrosis and anti-cancer RNAi therapeutics, strengthen the management team to support growth and bolster the Company pre-clinical development of new drug candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
401 Professional Dr. 280
Gaithersburg, MD 20879
USA
Gaithersburg, MD 20879
USA
Phone
Website
Email Address
Overview
Sirnaomics, Inc. is a biopharmaceutical company discovering and developing novel targeted therapeutics for critical human diseases by using RNA interference (RNAi) technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Lu
Chief Medical Officer
Michael Molyneaux
Chief Operating Officer
George Ji
Chief Scientific Officer
David Evans
Chief Technical Officer
Dmitry Samarsky
VP - Finance
Nigel Yip
VP - Human Resources
John Buergenthal
Browse more venture capital transactions:
Prev: 6/8/2018: Listo Financial venture capital transaction
Next: 6/8/2018: Figure Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs